Bucci Mary Kara, Maity Amit, Janss Anna J, Belasco Jean B, Fisher Michael J, Tochner Zelig A, Rorke Lucy, Sutton Leslie N, Phillips Peter C, Shu Hui-Kuo G
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Cancer. 2004 Aug 15;101(4):817-24. doi: 10.1002/cncr.20422.
Because few reports on outcome in patients with pediatric malignant gliomas during the magnetic resonance imaging era were available, the authors studied the outcomes of children with these tumors at their institution.
The medical records of 39 patients with nonbrainstem, malignant gliomas who were treated at the Hospital of the University of Pennsylvania/Children's Hospital of Philadelphia between February 1, 1989 and December 31, 2000 were reviewed retrospectively. Magnetic resonance imaging was used to assess tumors at presentation and at follow-up. Progression-free survival (PFS) and overall survival (OS) were determined using the Kaplan-Meier method. Univariate and multivariate analyses were performed using a Cox proportional hazards model.
The median follow-up for the 14 surviving patients was 47.6 months. The median PFS for all patients was 12.2 months, and the median OS for all patients was 21.3 months. The extent of surgery was the strongest prognostic factor for predicting outcomes in these patients, with a median survival of 122.2 months in patients who underwent macroscopic total resection compared with 14.1 months in patients who had significant residual disease after surgery. In univariate analyses, other than the extent of surgery, only the absence of visual symptoms at diagnosis significantly predicted improved OS. Local control was improved for patients who underwent better resection and had smaller tumors. In multivariate analyses, although the extent of surgery continued to predict outcomes significantly, histologic grade, which was not significant in the univariate analysis, also was significant.
Children with malignant gliomas appeared to fare better than their adult counterparts. Because the extent of resection was one of the strongest predictors of outcome, the authors concluded that the optimal therapy for these patients would include the maximal possible resection.
由于在磁共振成像时代,关于小儿恶性胶质瘤患者预后的报道较少,作者研究了其所在机构中患有这些肿瘤的儿童的预后情况。
回顾性分析了1989年2月1日至2000年12月31日期间在宾夕法尼亚大学医院/费城儿童医院接受治疗的39例非脑干恶性胶质瘤患者的病历。利用磁共振成像在初诊时和随访时评估肿瘤情况。采用Kaplan-Meier法确定无进展生存期(PFS)和总生存期(OS)。使用Cox比例风险模型进行单因素和多因素分析。
14例存活患者的中位随访时间为47.6个月。所有患者的中位PFS为12.2个月,中位OS为21.3个月。手术范围是预测这些患者预后的最强预后因素,接受肉眼全切的患者中位生存期为122.2个月,而术后有明显残留病灶的患者中位生存期为14.1个月。在单因素分析中,除手术范围外,只有诊断时无视觉症状能显著预测OS改善。接受更好切除且肿瘤较小的患者局部控制情况得到改善。在多因素分析中,尽管手术范围仍然是显著预测预后的因素,但组织学分级在单因素分析中不显著,在多因素分析中也具有显著性。
患有恶性胶质瘤的儿童似乎比成年患者预后更好。由于切除范围是预后的最强预测因素之一,作者得出结论,这些患者的最佳治疗方法应包括尽可能最大程度的切除。